ACCUSTEM SCIENCES, INC. Shareholders' Equity
ACCUSTEM SCIENCES, INC. (ACUT) had Shareholders' Equity of -$4.12 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$4.12M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$3.87M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$3.40M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$2.91M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$4.12M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$3.87M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | -$3.40M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$2.91M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$2.53M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$2.16M 10-Q · filed 2026-08-14 | -$2.16M 10-Q · filed 2025-05-20 |
| 2024-12-31 | -$3.31M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | -$3.19M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$2.88M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | -$2.62M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | -$2.11M 10-K · filed 2026-04-14 | |
| 2023-09-30 | -$1.89M 10-Q · filed 2024-11-18 | |
| 2023-06-30 | -$1.31M 10-Q · filed 2024-11-18 | |
| 2023-03-31 | -$946.68K 10-Q · filed 2024-09-16 | |
| 2022-12-31 | -$139.55K 10-K · filed 2025-04-03 | |
| 2022-09-30 | $797.72K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $1.65M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $2.69M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $650.67K 10-K · filed 2024-03-22 | |
| 2021-09-30 | $1.19M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.26M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $1.31M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $1.31M 10-K · filed 2023-02-15 |